Cutaneous leishmaniasis in a child treated with oral fluconazole

Australasian Journal of Dermatology

Volumn 51, Issue 3, 2010, Pages 195-197

  Sklavos, Angelo V ^a   Walls, Tony ^b   Webber, Murray T ^c,d   Watson, Alan B ^a  

^a Royal Newcastle Centre   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d Hunter New England Area Health Service   (Australia)

Author keywords

child; cutaneous leishmaniasis; fluconazole; infection; refugee; treatment

Indexed keywords

FLUCONAZOLE;

ARTICLE; AUSTRALIA; CASE REPORT; CHILD; CLINICAL FEATURE; FACE; FEMALE; HUMAN; LEISHMANIA MAJOR; NONHUMAN; PSYCHODIDAE; RIVER; SCAR FORMATION; SKIN GRANULOMA; SKIN INFILTRATE; SKIN LEISHMANIASIS; SKIN NECROSIS; SKIN ULCER; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; CEPHALEXIN; CHILD, PRESCHOOL; CICATRIX; FEMALE; FLUCONAZOLE; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS;

EID: 77955288340     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2010.00642.x     Document Type: Article

References (15)

1. González U, Pinart M, Reveiz L et al. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst. Rev. 2008 CD005067.
2. Zvulunov A, Vardy D, Cagnano E et al. Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B. Pediatr. Infect. Dis. J. 2003 22 : 567 569.
3. Alrajhi AA, Ibrahim EA, De Vol EB et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N. Engl. J. Med. 2002 346 : 891 895.
4. González-Llavona B, Biosca-Echenique G, Soto-Díaz A et al. Cutaneous leishmaniasis in a Senegal patient. Actas Dermosifiliogr. 2007 98 : 54 8.
5. Boakye DA, Wilson MD, Kweku M. A review of leishmaniasis in West Africa. Ghana Med. J. 2005 39 : 94 7.
6. Urbanization: an increasing risk factor for leishmaniasis. Wkly. Epidemiol. Rec. 2002 77 : 365 370.
7. Desjeux P, Alvar J. Emerging Leishmania/HIV co-infection in Africa. Med. Microbiol. Immunol. 2001 190 : 65 7.
8. Murray HW, Berman JD, Davies CR et al. Advances in leishmaniasis. Lancet 2005 366 : 1561 1577.
9. Bongiorno MR, Pistone G, Aricò M. Unusual clinical variants of cutaneous leishmaniasis in Sicily. Int. J. Dermatol. 2009 48 : 286 289.
10. Walsh DS, Balagon MV, Abalos RM et al. Multiple lesions of sporotrichoid leishmaniasis in a Filipino expatriate. J. Am. Acad. Dermatol. 1997 36 : 847 849.
11. Uthman MA, Satir AA, Tabbara KS. Clinical and histopathological features of zoonotic cutaneous leishmaniasis in Saudi Arabia. J. Eur. Acad. Dermatol. Venereol. 2005 19 : 431 436.
12. Morizot G, Delgiudice P, Caumes E et al. Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution? Am. J. Trop. Med. Hyg. 2007 76 : 48 52.
13. Anon. Drugs for parasitic infections. Med. Lett. Drugs Ther. 1992 34 : 17 24.
14. Aronson NE, Wortmann GW, Johnson SC et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin. Infect. Dis. 1998 27 : 1457 1464.
15. Ameen M. Cutaneous leishmaniasis: therapeutic strategies and future directions. Expert. Opin. Pharmacother. 2007 8 : 2689 2699.